Some Women in Their 40s Prefer to Delay Breast Cancer Screening

Follow Drugslib on

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

MONDAY, July 15, 2024 -- A considerable proportion of women aged 39 to 49 years prefer to delay breast cancer screening, especially after a decision aid (DA) intervention, according to a study published online July 16 in the Annals of Internal Medicine.

Laura D. Scherer, Ph.D., from the University of Colorado School of Medicine in Aurora, and colleagues examined breast cancer screening preferences among women aged 39 to 49 years in a pre-post survey with a breast cancer screening decision aid (DA) intervention. The analyses included 495 women without a history of breast cancer or known BRCA1/2 gene mutation.

The researchers found that 27.0 percent of participants preferred to delay screening (versus having a mammography at their current age) before viewing the DA compared with 38.5 percent after the DA. The number never wanting mammography did not increase (5.4 percent before the DA versus 4.3 percent after). The risk for breast cancer was lower for participants who preferred to delay screening than those who preferred not to delay. Overall, 37.4 percent of participants reported that the information about overdiagnosis was surprising compared with 27.2 and 22.9 percent for information about false-positive results and screening benefits, respectively.

"These data emphasize the importance of reducing barriers to receiving desired care as well as informing women about mammography benefits, harms, and personal cancer risk estimates as a regular part of screening consultations," the authors write.

Abstract/Full Text (subscription or payment may be required)

Editorial (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-07-16 07:15

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords